Randomized trial to compare two standardized surgical approaches in rectal prolapse - Delorme's procedure vs. laparoscopic resection rectopexy (DeloRes)
Randomized trial to compare two standardized surgical approaches in rectal prolapse - Delorme's procedure vs. laparoscopic resection rectopexy (DeloRes)
批准号:
130241905
负责人:
Professor Dr. Stefan Post
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Clinical Trials
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Full-thickness prolapse of the rectum causes significant discomfort. Treatment is usually surgical, over 100 approaches are described. The most important are the perineal and transabdominal techniques.Aim is to correct rectal prolapse, to restore normal bowel function and to avoid recurrence. An optimal surgical treatment for all patients with rectal prolapse does not exist. In general, perineal surgical repairs cause less morbidity. They are especially indicated in elderly or high-risk patients. The most frequently used perineal approach is Delorme´s procedure. Recurrences seem more frequent after perineal techniques. Laparoscopic resection rectopexy is suggested to yield better results in the early postoperative phase compared to the open approach with equal recurrence rates. There is no valid evidence in regard to the preferred surgical procedure. A successful prospective randomized, adequately powered trial comparing these two established operation techniques has never been completed. The published trial registers do not indicate that there is currently an ongoing trial investigating this question.The aim of this trial is primarily to compare the time-to-recurrence after repair of full-thickness rectal prolapse by Delorme´s procedure versus laparoscopic resection rectopexy during a 2-year follow-up.Secondary endpoints are time to and incidence of recurrence of full-thickness rectal prolapse during 5- year follow-up, duration of surgical intervention, morbidity, mortality, length of hospital stay, reoperation rate for recurrent prolapse, cumulative hospital stay due to primary operation and following hospitalizations because of complications or recurrence within 24 months after randomization, quality of life, constipation and incontinence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
-
批准号:81973152
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2019
-
负责人:胡东生
-
依托单位: